Stockreport

Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Zenas BioPharma, Inc.  (ZBIO) 
PDF WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company co [Read more]